References:
- Puetz J, Cheng D. Descriptive analysis of bleeding symptoms in
haemophilia carriers enrolled in the ATHNdataset. Haemophilia.2021;27(6):1045-1050.
- Paroskie A, Gailani D, DeBaun MR, Sidonio RF Jr. A cross-sectional
study of bleeding phenotype in haemophilia A carriers. Br J
Haematol. 2015;170(2):223-8.
- Plug I, Mauser-Bunschoten EP, Brocker-Vriends AH et al. Bleeding in
carriers of hemophilia. Blood . 2006;108(1):52-6
- Van Galen K, d’Oiron R, James P et al. A new hemophilia carrier
nomenclature to define hemophilia in women and girls: Communication
from the SSC of the ISTH. J Thromb Haemost.2021;19(8):1883-188.
- Elbatarny M, Mollah S, Grabell J et al. Normal range of bleeding
scores for the ISTH-BAT: adult and pediatric data from the merging
project. Haemophilia. 2014;20(6):831-5.
- Doherty D, Grabell J, Christopherson P et al. Variability in
International Society on Thrombosis and Haemostasis=Scientific and
Standardization Committee endorsed Bleeding Assessment Tool (ISTH-BAT)
score with normal aging in healthy females:contributory factors and
clinical significance. J Thromb Haemost 2023:21:880-886.
- Jain S, Zhang S, Acosta M, Malone K, Kouides P, Zia A. Prospective
evaluation of ISTH-BAT as a predictor of bleeding disorder in
adolescents presenting with heavy menstrual bleeding in a
multidisciplinary hematology clinic. J Thromb Haemost2020;18(10):2542-2550.
- Biguzzi E, Castelli F, Lijfering W et al. Rise of levels of von
Willebrand factor and factor VIII with age: Role of genetic and
acquired risk factors. Thromb Res 2021;197:172-178.
- Appel I, Grimminck B,GeertsJ et al. Age dependency of coagulation
parameters during childhood and puberty. J Thromb Haemost 2012;
10:2254-2263.
- Puetz J, Johnson L, Hugge C, Buchanan P. First Look at My Life, Our
Future Carrier Data from a Pilot Site. Res Pract Thromb
Haemost. 2018;2(S1):60.
- Young JE, Grabell J, Tuttle A et al. Evaluation of the
self-administered bleeding assessment tool (Self-BAT) in haemophilia
carriers and correlations with quality of life. Haemophilia.2017;23(6):e536-e8.
- Li S, Fang Y, Li L et al. Bleeding assessment in haemophilia
carriers-High rates of bleeding after surgical abortion and
intrauterine device placement: A multicentre study in China.Haemophilia. 2020;26(1):122-8.
- Baud’huin M, Duplomb L, Teletchea S et al. Factor VIII-von Willebrand
Factor Complex Inhibits Osteoclastogenesis and Controls Cell Survival.J Biol Chem 2009;284(46)31704-31713.
- Citla-Sridhar D, Sidonio R, Ahuja S. Bone health in haemophilia
carriers and persons with von Willebrand disease: A large database
analysis. Haemophilia 2022;28(4):671-678.
- Saes J, Verhagen M, Meijer K et al. Bleeding severity in patients with
rare bleeding disorders: real-life data from the RBiN study.Blood Adv 2020;4(20):5025-5034.
- Puetz J, Hugge C, Moser K. Normal aPTT in children with factor XI
deficiency. Pediatr Blood Cancer 2018;65(4):e26910
- Wheeler A, Gailani D. Why factor XI deficiency is a clinical concern.Expert Rev Hematol 2016;9(7):629-637.
- Peyvandi F, Palla R, Menegatti M et al. Coagulation factor activity
and clinical bleeding severity in rare bleeding disorders: results
from the European Network of Rare Bleeding Disorders. J Thromb
Haemost 2012;10(4):615-621.
- Den Uijl I, Bunschoten E, Roosendaal G et al. Clinical severity of
haemophilia A: does the classification of the 1950s still stand?Haemophia 2011;17(6):849-853.
- Borry P, Fryns J, Schotsmans P, Dierickx K. Carrier testing in minors:
a systematic review of guidelines and position papers. Eur J Hum
Genet 2005;14(2):133-138.
- Committee on Bioethics,
Committee on Genetics, and The American College of Medical Genetics
and Genomics Social, Ethical and Legal Issues Committee. Ethical and
Policy Issues in Genetic Testing and Screening of Children.Pediatrics 2013;131(3):620-622.
- Vears D, Metcalfe S. Carrier testing in children and adolescents.Eur J Hum Genet 2015;58(12):659-667.
- James PD, Mahlangu J, Bidlingmaier C et al. Evaluation of the utility
of the ISTH-BAT in haemophilia carriers: a multinational study.Haemophilia. 2016;22(6):912-8.
- Tosetto A, Rodeghiero F, Castaman G et al. A quantitative analysis of
bleeding symptoms in type 1 von Willebrand disease: results from a
multicenter European study (MCMDM-1 VWD). J Thromb Haemost.2006;4(4):766-73.
- Olsson A, Hellgren M, Berntorp E, Ljung R, Baghaei F. Clotting factor
level is not a good predictor of bleeding in carriers of haemophilia A
and B. Blood Coagul Fibrin. 2014;25(5):471-5.
- Miesbach W, Alesci S, Geisen C, Oldenburg J. Association between
phenotype and genotype in carriers of haemophilia A.Haemophilia 2011;17(2):246-251.